CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a dual therapy for osteoarthritis by regenerating damaged cartilage and dissolving bone fragments using a combination of biosilica and polyphosphate. The innovative approach targets pain relief and tissue repair, offering a potential solution for millions affected by this condition.
Osteoarthritis (OA) is the most common form of arthritis of the joints, affecting over 70 million EU citizens.
At present, no cure for OA is available; only symptomatic therapies may help to ameliorate this painful disorder. OA affects the integrity of the cartilage and progresses to an increased damage in its surrounding tissues, inclusive bone, and to inflammation of the synovial tissue.
The latter reaction is caused by an accumulation of bone splinters.
The therapy of choice would be – if ava…
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
